TFS HealthScience and VERIGRAFT announce a partnership to advance P-TEV through pivotal Phase II/III trial in chronic venous insufficiency.
Read More
Our 2025 sustainability year in review shows major progress: −17% emissions, 99% renewable electricity, SBTi‑validated targets, and stronger ESG ratings.
TFS HealthScience achieves a B score in the 2025 CDP Climate Change assessment, demonstrating strengthened climate governance and responsible CRO practices.
TFS expands its global neuroscience portfolio, strengthening its gene therapy expertise across neurodegenerative diseases through innovation & collaboration.
TFS HealthScience has received validation from the Science Based Targets initiative (SBTi) for its near-term and net-zero greenhouse gas reduction goals, underscoring its commitment to science-based decarbonization and a healthier, more sustainable world.
TFS HealthScience, a leading global Contract Research Organization, is expanding its ophthalmology business unit with new leadership talent and enhanced delivery capabilities to meet rising demand for specialized clinical trial execution in eye care.
Markus Granlund, who has been serving as Interim CEO of TFS HealthScience since February 2025, has officially been appointed as the company’s Chief Executive Officer, effective immediately.
TFS shares ESG progress in its 2024 Sustainability Report, highlighting emissions cuts and a global commitment to people and the planet.
Recognition highlights the CRO’s global expansion strategy, sponsor-focused execution, and commitment to operational excellence. LUND, S.E., May 14, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO),…
LUND, S.E., May 6, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with Oncomatryx, a biopharmaceutical company developing novel antibody-drug conjugates (ADCs)…
LUND, S.E., April 29, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is advancing the next phase of its strategic growth journey under CEO Markus Granlund….
TFS HealthScience has been named a 2025 Life Sciences Award winner by Triangle Business Journal in recognition of its scientific expertise, operational excellence, and growing impact within North Carolina’s dynamic life sciences ecosystem.
LUND, S.E., April 2, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces continued advancement in its sustainability journey, marked by a strengthened assessment from CDP, formerly the Carbon Disclosure Project.
LUND, S.E., April 2, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces continued advancement in its sustainability journey, marked by a strengthened assessment from CDP, formerly the Carbon Disclosure Project.
LUND, S.E., March 25, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce that Miriam Martin, a long-standing member of the organization, has…